80 likes | 111 Views
Get more details @ http://bit.ly/2pcvnbg <br>Global biopsy device market share is oligopolistic in nature with very few players accounting to over 90% of the market share in 2015. C.R. Bard dominated the global share in 2015. The other key players include Devicor Medical Products Inc., CareFusion Corporation and Hologic Inc.
E N D
Biopsy Devices Market to grow at 6.5% CAGR from 2016 to 2024:Global Market Insights Inc. Fuel Cell Market size worth $25.5bn by 2024
Key Insights from Biopsy Devices Market: • Global Market Insights, Inc., Global Biopsy Devices Market size was valued at $1.76 billion for 2015 and is projected to record CAGR of about 6.6% during forecast timeframe. • Rising occurrence of cancer, increasing demand for minimally invasive drug procedures and enhanced expenditure on efficient investigative methods are few of the main aspects promoting industry growth. • Rise in proportion of patients suffering from cancer ailment is predicted produce heavy demand for biopsy methods. Launch of new government policies aimed at enhancing compensation coverage like Obamacare Act in countries like U.S. is predicted to broaden the customer base. • Global biopsy devices industry is segmented into various products like needle based biopsy gun, biopsy forceps, biopsy needles and biopsy guidance system. • Needle based biopsy gun segment is sub-segmented into core needle segment, vacuum-assisted segment and fine needle segment.
Continued... • Biopsy forceps segment is also segmented into sub-segments like hot biopsy segment and general biopsy segment. Biopsy needles segment is segmented into reusable segment and disposable segment. • Biopsy guidance system is sub-segmented into robotic and manual segments. Biopsy guidance system dominated the product segment and it was followed by needle based biopsy gun segment as well as biopsy needles segment. • North American industry was biggest regional industry contributing about more than 55.1% to the total industry share for 2015 and was followed by Europe and APAC. • U.S. biopsy devices market price was about $1.2 billion for 2015 with contribution more than 80.1% to the North America biopsy devices industry share. • Key industry players profiled in the report include Hologic Incorporation, Devicor Medical Products Incorporation, Surgical Specialities Corporation, CareFusion Corporation, Cardinal Health Incorporation, C.R. Bard Incorporation, DTR Medical and INRAD Incorporation.
Table of Content: Chapter 1. Methodology and Scope 1.1. Research Methodology 1.1.1. Initial data exploration 1.1.2. Statistical modeling and forecast 1.1.3. Industry insights and validation 1.2. Data Sources Chapter 2. Executive Summary 2.1. Biopsy Devices industry 3600 synopsis, 2012 - 2024 2.1.1. Business trends 2.1.2. Regional trends 2.1.3. Product trends
Table of Content: Chapter 3. Biopsy Devices Industry Insights 3.1. Industry segmentation 3.2. Industry Size and forecast, 2012 - 2024 3.3. Industry Impact forces 3.3.1. Growth drivers 3.3.1.1. Presence of huge geriatric population base 3.3.1.2. Growing prevalence of cancer 3.3.1.3. Rising need for effective diagnostic procedures 3.3.1.4. Increasing preference for minimally invasive procedures 3.3.2. Industry pitfalls & challenges 3.3.2.1. Capital-intensive products 3.4. Growth potential analysis 3.5. Porter’s analysis 3.6. PESTEL analysis 3.7 Company market Share Analysis, 2015
U.S. Biopsy Devices Market Size, by Product, 2012- 2024 (USD Million)
Browse Full Market Research Report On Biopsy Devices Market @ http://bit.ly/2pMVKGs Request for a Sample of this Research Report @ https://www.gminsights.com/request-sample/detail/731
Stay In Touch Website: www.gminsights.com Social Media: